Real-time enrollment status for this relapsed neuroblastoma clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 11:14 PM UTC
| NCT Number | NCT04211675 |
| Recruiting Status | Recruiting |
| Condition | Relapsed Neuroblastoma |
| Phase | PHASE1 |
| Target Enrollment | 31 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Nationwide Children's Hospital |
| Last Updated on CT.gov | May 13, 2025 (May 13, 2025) |
As of August 29, 2026: Clinical trial NCT04211675 is currently recruiting participants. This phase1 study for relapsed neuroblastoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Nationwide Children's Hospital. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04211675 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04211675 was last updated May 13, 2025 (May 13, 2025). HelloStudys verifies this status automatically.